Phase:Demo Project
Principal Investigator(s):
Objective:This is a multi-site, prospective, open-label, population-level PrEP demonstration study, the primary aim of which is to determine whether the use of daily PrEP by 2,600 Victorians who are at high risk of HIV infection will reduce the number of new HIV infections in Victoria in the following one to three years.
Prevention Option(s):PrEP
Study Design:
Official Code: PrEPX
Trial Sponsors: Alfred Health and the Victorian AIDS Council, Victorian Government
Start Date
End Date
July 26, 2016
March 29, 2018
Age range: 18 Years ↔ any
Population:Cisgender Men, Cisgender Women, Gay and Bisexual Men Who Have Sex with Men